Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial.
about
Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphomaChlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trialThe role of antigenic drive and tumor-infiltrating accessory cells in the pathogenesis of helicobacter-induced mucosa-associated lymphoid tissue lymphoma.Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.Hepatic dysfunction after radiotherapy for primary gastric lymphoma.Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.Treatment of gastric marginal zone lymphoma of MALT type.Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma.Helicobacter pylori in gastric malignancies.Extranodal and splenic small B-cell lymphoma.Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes.Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma.Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up.Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice.Primary gastric lymphoma.Recent advances in understanding the biology of marginal zone lymphoma.
P2860
Q26851987-781D99CA-BB28-4571-968F-B091F52926B1Q34600972-FAE3E876-420C-429F-9513-B72A54896F1BQ35221772-7BB8A10A-F3D7-4D8F-820F-7DA0984AE606Q36407449-A9860B8C-8546-4B8D-AB81-094DDAA7C73EQ36499990-F5B41407-D2AE-4FFC-9C2D-A5834C6719E9Q36584820-60CD7C16-EBFE-4CFF-924B-978F7D618F26Q36677699-FD5E9026-0F88-4C4B-B157-E4F392DFD119Q36768594-31CD9F8F-894D-4630-8982-BC91AE486953Q37768456-D4F7765D-0281-439B-B095-9ED10997C925Q37932613-3EDBDCE7-163B-42FA-9ADF-E292AC98E9E6Q38051229-80122C2F-4A0E-46C8-8EEB-F577F6A766A0Q38071075-12813DE6-A3C3-4AD7-985C-2C5A58511B0EQ39940415-10329C68-E738-49C1-A5AA-A9CD68376846Q43005367-9621BE49-0262-4F03-924D-F683A478BD87Q43206352-F6022F41-22B2-4113-8F81-011EAFBE80B3Q45150144-AFDE4A5E-7331-46C5-B102-1DC8B9ECA01DQ54736050-EA6D010B-3E84-4914-9246-8FB905A77A02Q55106506-623EA999-DAB6-4D72-AB10-C558E1DE5AD8
P2860
Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Molecular follow-up in gastric ...... of the LY03 cooperative trial.
@en
Molecular follow-up in gastric ...... of the LY03 cooperative trial.
@nl
type
label
Molecular follow-up in gastric ...... of the LY03 cooperative trial.
@en
Molecular follow-up in gastric ...... of the LY03 cooperative trial.
@nl
prefLabel
Molecular follow-up in gastric ...... of the LY03 cooperative trial.
@en
Molecular follow-up in gastric ...... of the LY03 cooperative trial.
@nl
P2093
P356
P1433
P1476
Molecular follow-up in gastric ...... of the LY03 cooperative trial.
@en
P2093
Andrea Biondi
Annarita Conconi
Barry William Hancock
Carlo Capella
Domenico Novero
Emanuele Zucca
Ennio Pedrinis
Finbarr E Cotter
Franco Cavalli
Giovanni Cazzaniga
P304
P356
10.1182/BLOOD.V99.7.2541
P407
P577
2002-04-01T00:00:00Z